Parkinson's Disease Sleep Scale-2: The Brazilian Version's Cross-Cultural Adaptation and Validation.

IF 1 Q4 CLINICAL NEUROLOGY
Sleep Science Pub Date : 2025-03-11 eCollection Date: 2025-06-01 DOI:10.1055/s-0044-1791977
Rogério José de Souza, Amanda Dos Santos Siqueira, Luísa Vigiani Cassiano, Tais Caroline Oliveira da Silva, Suhaila Mahmoud Smaili
{"title":"Parkinson's Disease Sleep Scale-2: The Brazilian Version's Cross-Cultural Adaptation and Validation.","authors":"Rogério José de Souza, Amanda Dos Santos Siqueira, Luísa Vigiani Cassiano, Tais Caroline Oliveira da Silva, Suhaila Mahmoud Smaili","doi":"10.1055/s-0044-1791977","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective</b>  To translate, cross-culturally adapt, and validate the Brazilian version of the Parkinson's Disease Sleep Scale-2 (PDSS-2/BR). <b>Methods</b>  This cross-sectional study addressed 80 patients with PD, and it was organized into two phases: 1) Translation and cross-cultural adaptation, which included 30 individuals in the scale's pretest stage and 2) Validation, when 50 individuals were assessed by the PDSS-2/BR, Pittsburgh Sleep Quality Index (PSQI), Parkinson's Disease Questionnaire-39 (PDQ-39), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and Hoehn and Yahr rating scale (HY); the PDSS-2/BR was retested 7 days later. The significance level was set at 5%. <b>Results</b>  The participants rated the PDSS-2/BR as having more than 90% comprehension. It also showed good reliability (Cronbach's alpha = 0.782) and excellent test-retest reliability (ICC <sub>interrater</sub>  = 0.901; <i>p</i>  = 0.570; ICC <sub>intrarater</sub>  = 0.905; <i>p</i>  = 0.116). Additionally, the scale showed good precision, with low standard error of measurement (SEM <sub>inter</sub>  = 1.040; SEM <sub>intra</sub>  = 0.908), and moderate to strong correlation with the PSQI, MDS-UPDRS, and PDQ-39 scales (rho = 0.46-0.74); only the HY scale showed no correlation. <b>Discussion</b>  The PDSS-2/BR is a reliable, precise, and valid instrument for evaluating sleep among Brazilian individuals with PD. Hence, it is expected to help researchers and clinicians improve the investigation of these symptoms, promoting early and assertive diagnoses and guiding the treatment and clinical management of this population.</p>","PeriodicalId":21848,"journal":{"name":"Sleep Science","volume":"18 2","pages":"e182-e189"},"PeriodicalIF":1.0000,"publicationDate":"2025-03-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12263210/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sleep Science","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1055/s-0044-1791977","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective  To translate, cross-culturally adapt, and validate the Brazilian version of the Parkinson's Disease Sleep Scale-2 (PDSS-2/BR). Methods  This cross-sectional study addressed 80 patients with PD, and it was organized into two phases: 1) Translation and cross-cultural adaptation, which included 30 individuals in the scale's pretest stage and 2) Validation, when 50 individuals were assessed by the PDSS-2/BR, Pittsburgh Sleep Quality Index (PSQI), Parkinson's Disease Questionnaire-39 (PDQ-39), MDS-Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and Hoehn and Yahr rating scale (HY); the PDSS-2/BR was retested 7 days later. The significance level was set at 5%. Results  The participants rated the PDSS-2/BR as having more than 90% comprehension. It also showed good reliability (Cronbach's alpha = 0.782) and excellent test-retest reliability (ICC interrater  = 0.901; p  = 0.570; ICC intrarater  = 0.905; p  = 0.116). Additionally, the scale showed good precision, with low standard error of measurement (SEM inter  = 1.040; SEM intra  = 0.908), and moderate to strong correlation with the PSQI, MDS-UPDRS, and PDQ-39 scales (rho = 0.46-0.74); only the HY scale showed no correlation. Discussion  The PDSS-2/BR is a reliable, precise, and valid instrument for evaluating sleep among Brazilian individuals with PD. Hence, it is expected to help researchers and clinicians improve the investigation of these symptoms, promoting early and assertive diagnoses and guiding the treatment and clinical management of this population.

帕金森氏症睡眠量表-2:巴西版的跨文化适应与验证。
目的翻译、跨文化适应和验证巴西版帕金森病睡眠量表-2 (PDSS-2/BR)。方法对80例PD患者进行横断面研究,分为两个阶段:1)翻译和跨文化适应阶段,其中30例为量表预试阶段;2)验证阶段,其中50例采用PDSS-2/BR、匹兹堡睡眠质量指数(PSQI)、帕金森病问卷-39 (PDQ-39)、mds -统一帕金森病评定量表(MDS-UPDRS)和Hoehn and Yahr评定量表(HY)进行评估;7 d后复查PDSS-2/BR。显著性水平设为5%。结果被试对PDSS-2/BR的理解程度在90%以上。具有良好的信度(Cronbach’s alpha = 0.782)和良好的重测信度(ICC interrater = 0.901;P = 0.570;ICC intrarater = 0.905;P = 0.116)。该量表精度好,测量标准误差低(SEM inter = 1.040;SEM intra = 0.908),与PSQI、MDS-UPDRS和PDQ-39量表有中强相关性(rho = 0.46-0.74);只有HY量表无相关性。PDSS-2/BR是一种可靠、精确、有效的评估巴西PD患者睡眠的工具。因此,它有望帮助研究人员和临床医生改进对这些症状的调查,促进早期和果断的诊断,并指导这一人群的治疗和临床管理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sleep Science
Sleep Science CLINICAL NEUROLOGY-
CiteScore
2.50
自引率
12.50%
发文量
124
审稿时长
10 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信